← Eichor
Study identifier: NCT05152264 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

Condition: Endometriosis-related Pain  ·  Sponsor: Göteborg University

PhaseNA
Planned participants40
Who can joinFemale, 18 Years to 100 Years
Healthy volunteersNo

About this study

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Paulin Andréll, MD, PhD  ·  +46-31-3438259  ·  paulin.andrell@gu.se

Cecilia Ögren, RN  ·  +46-31-3425000  ·  cecilia.ogren@vgregion.se

Always discuss trial participation with your own doctor first.

Locations (1)

Pain Centre, Department of Anaesthesiology and Intensive Care Medicine Östra, Sahlgrenska University Hospital, Region Västra GötalandGothenburg, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05152264